Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.
Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O'Rahilly S, Aveyard P, Jebb SA. · 2021
Read Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. by Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O'Rahilly S, Aveyard P, Jebb SA. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8081400.txt.
Introduction
Gao and co-authors chart how body-mass index tracks COVID-19 severity across England. Their prospective cohort drew on GP records in the QResearch database. The set held 6,910,695 adults with a known BMI. Outcomes ran from January to April 2020. In that window, 13,503 people were admitted to hospital with the virus. A further 1,601 reached intensive care, and 5,479 died.
Risk bottomed out near a BMI of 23 kg/m2 and rose in a J shape from there. Each extra unit above that point raised hospital risk, with a hazard ratio of 1.05 per unit in the adjusted models. ICU risk climbed in a straight line across the whole range. The BMI effect ran stronger in younger adults. It also ran stronger in Black people than in White people. Heart disease and diabetes did not explain the pattern away.
Catalog record
| CREATOR | Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O'Rahilly S, Aveyard P, Jebb SA. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study By Min Gao, Carmen Piernas, Nerys M Astbury, Julia Hippisley-Cox, Stephen O'Rahilly, Paul Aveyard, Susan A Jebb Published in: The Lancet. Diabetes & Endocrinology DOI: 10.1016/S2213-8587(21)00089-9 ABSTRACT Summary Background Obesity is a major risk factor for adverse outcomes after infection with SARS-CoV-2. We aimed to examine this association, including interactions with demographic and behavioural characteristics, type 2 diabetes, and other health conditions. Methods In this prospective, community-based, cohort study, we used de-identified patient-level data from the QResearch database of general practices in England, UK. We extracted data for patients aged 20 years and older who were registered at a practice eligible for inclusion in the QResearch database between Jan 24, 2020 (date of the first recorded infection in the UK) and April 30, 2020, and with available data on BMI. Data extracted included demographic, clinical, clinical values linked with Public Health England's database of positive SARS-CoV-2 test results, and death certificates from the Office of National Statistics. Outcomes, as a proxy measure of severe COVID-19, were admission to hospital, admission to an intensive care unit (ICU), and death due to COVID-19. We used Cox proportional hazard models to estimate the risk of severe COVID-19, sequentially adjusting for demographic characteristics, behavioural factors, and comorbidities. Findings Among 6 910 695 eligible individuals (mean BMI 26·78 kg/m2 [SD 5·59]), 13 503 (0·20%) were admitted to hospital, 1601 (0·02%) to an ICU, and 5479 (0·08%) died after a positive test for SARS-CoV-2. We found J-shaped associations between BMI and admission to hospital due to COVID-19 (adjusted hazard ratio [HR] per kg/m2 from the nadir at BMI of 23 kg/m2 of 1·05 [95% CI 1·05–1·05]) and death (1·04 [1·04–1·05]), and a linear association across the whole BMI range with ICU admission (1·10 [1·09–1·10]). We found a significant interaction between BMI and age and ethnicity, with higher HR per kg/m2 above BMI 23 kg/m2 for younger people (adjusted HR per kg/m2 above BMI 23 kg/m2 for hospital admission 1·09 [95% CI 1·08–1·10] in 20–39 years age group vs 80–100 years group 1·01 [1·00–1·02]) and Black people than White people (1·07 [1·06–1·08] vs 1·04 [1·04–1·05]). The risk of admission to hospital and ICU due to COVID-19 associated with unit increase in BMI was slightly lower in people with type 2 diabetes, hypertension, and cardiovascular disease than in those without these morbidities. Interpretation At a BMI of more than 23 kg/m2, we found a linear increase in risk of severe COVID-19 leading to admission to hospital and death, and a linear increase in admission to an ICU across the whole BMI range, which is not attributable to excess risks of related diseases. The relative risk due to increasing BMI is particularly notable people younger than 40 years and of Black ethnicity. Funding NIHR Oxford Biomedical Research Centre. INTRODUCTION Early in the COVID-19 pandemic, obesity was implicated as a clinically significant risk factor for severe disease.1, 2 Multiple studies have supported this theory, and several systematic reviews and meta-analyses on this subject have been published to date.3, 4, 5 However, this association might occur due to a special form of collider bias, termed index event bias.6 Almost all studies of this potential association to date have examined outcomes of patients admitted to hospital and compared progression to intensive care unit (ICU) or death between those with and without obesity. Because either obesity itself or the severity of COVID-19 disease could prompt admission to hospital, the association between these factors might be spurious. A large population-based study, which avoided the risk of collider bias, found that having a body-mass index (BMI) of 30 kg/m2 or higher was associated with a slightly greater risk of death from COVID-19 than a BMI of less than 30 kg/m2.7 However, this study did not examine the risk of unit increases in BMI across the population, of which a large proportion have a BMI lower than 30 kg/m2. Some studies have found that male gender, some ethnic groups, and people with type 2 diabetes and other chronic conditions might be at higher risk of adverse outcomes from severe SARS-CoV-2 infection.7, 8, 9, 10, 11 Whether these characteristics interact with the effect of excess weight is unclear. Here we report results of a large, representative community-based cohort study of 6·9 million people in England, UK, to thoroughly characterise the association between BMI and severe COVID-19 outcomes and to explore interactions with demographic characteristics and other known risk factors. Research in contextEvidence before this studySeveral systematic reviews and meta-analyses have reported that obesity is associated with adverse outcomes after infection with SARS-CoV-2 but most studies included people admitted to hospital with COVID-19 symptoms and so could be potentially affected by collider bias, where obesity itself and the severity of COVID-19 disease increase the likelihood of hospital admission. A previous population-based study focused on the effect of obesity (BMI ≥30 kg/m2) but did not take into account the consequences of excess weight (ie, a BMI of >25 kg/m2) for the majority of the population who do not have obesity. Whether excess weight poses the same risk for all demographic groups or people with chronic health conditions is unclear.Added value of this studyIn this very large, community-based cohort study, we found that the hazard ratio of severe outcomes from COVID-19 (ie, admission to hospital, admission to ICU, or death) increase progressively above a BMI of 23 kg/m2, which is not attributable to excess risks of related diseases such as type 2 diabetes. We found that BMI is a greater risk factor for younger people (aged 20–39 years) than for older people (≥80 years), and for Black people than for White people.Implications of all the available evidenceEven a small increase in BMI above 23 kg/m2 is a risk factor for adverse outcomes after infection with SARS-CoV-2. People with excess weight, even without other comorbidities, are at substantially increased risk of admission to hospital and ICU and death due to COVID-19, especially for younger adults and Black people. Excess weight is a modifiable risk factor and investment in the treatment of overweight and obesity and long-term preventive strategies could help reduce the severity of COVID-19 disease. METHODS Study design and participants In this prospective, community-based, cohort study, we used data from an anonymised research database of patients from over 1500 English general practices (QResearch version 44). The data include demographic information, medical diagnoses, prescriptions, referrals, laboratory results, and clinical values linked with data from Public Health England's (PHE's) database of SARS-CoV-2 positive PCR tests, and to Hospital Episode Statistics and death certificates from the Office for National Statistics. We extracted deidentified patient-level data between Jan 24, 2020 (date of the first recorded infection in the UK), and April 30, 2020, from the QResearch database for all individuals aged 20–99 years who were registered at a general practice (GP) that contributes to the QResearch database and had available BMI data. The QResearch database was approved by the East Midlands Derby Research Ethics Committee (reference 18/EM/0400), which waived the need for written informed consent for collection of deidentified patient data. In accordance with this ethical approval, the protocol for this study was reviewed and approved